Persistent Expression of Recipient-type ABH Antigen after ABO-incompatible Allogeneic Hematopoietic Stem Cell Transplantation

1Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

In general, the recipient’s ABO blood type changes to the donor’s ABO blood type after ABO-incompatible allogeneic hematopoietic stem cell transplantation (HSCT). However, we experienced a 26-year-old male with acute myelogenous leukemia (AML) who underwent ABO-incompatible HSCT twice and persistently showed his original blood type even after demonstrating complete donor-type chimerism. Based on the results of various examinations, we considered that the antigen of the recipient’s original blood type persistently synthesized in the recipient’s non-hematopoietic organs was secreted and adsorbed on the surface of donor-derived RBCs. We should therefore perform detailed examinations to determine the precise blood type after ABO-incompatible HSCT.

Cite

CITATION STYLE

APA

Misaki, Y., Kako, S., Kawamura, S., Takeshita, J., Yoshino, N., Yoshimura, K., … Kanda, Y. (2022). Persistent Expression of Recipient-type ABH Antigen after ABO-incompatible Allogeneic Hematopoietic Stem Cell Transplantation. Internal Medicine, 61(12), 1887–1890. https://doi.org/10.2169/internalmedicine.8315-21

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free